PHASE-II TRIAL OF 4'-(9-ACRIDINYLAMINO)METHANESULFON-M-ANISIDIDE (AMSA) IN THE TREATMENT OF ADVANCED NON-HODGKINS LYMPHOMA

被引：0
|
作者：
WARRELL, RP [1 ]
STRAUS, DJ [1 ]
YOUNG, CW [1 ]
机构：
[1] MEM SLOAN KETTERING CANC CTR,HEMATOL LYMPHOMA SERV,NEW YORK,NY 10021
来源：
CANCER TREATMENT REPORTS | 1980年 / 64卷 / 10-1期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1157 / 1158
页数：2
相关论文
共 50 条
  • [31] INVITRO CHEMOSENSITIVITIES OF HUMAN-TUMOR STEM-CELLS TO THE PHASE-II DRUG 4'-(9-ACRIDINYLAMINO)METHANESULFON-M-ANISIDIDE AND PROSPECTIVE INVIVO CORRELATIONS
    AHMANN, FR
    MEYSKENS, FL
    MOON, TE
    DURIE, BGM
    SALMON, SE
    CANCER RESEARCH, 1982, 42 (11) : 4495 - 4498
  • [32] HUMAN PHARMACOKINETICS OF A NEW ACRIDINE DERIVATIVE, 4'-(9-ACRIDINYLAMINO)METHANESULFON-M-ANISIDIDE (NSC 249992)
    HALL, SW
    FRIEDMAN, J
    LEGHA, SS
    BENJAMIN, RS
    GUTTERMAN, JU
    LOO, TL
    CANCER RESEARCH, 1983, 43 (07) : 3422 - 3426
  • [33] TEMPORARY EFFECTS OF AMSA (4'-(9-ACRIDINYLAMINO) METHANESULFON-META-ANISIDIDE) CHEMOTHERAPY ON SPERMATOGENESIS
    DACUNHA, MF
    MEISTRICH, ML
    HAQ, MM
    GORDON, LA
    WYROBEK, AJ
    CANCER, 1982, 49 (12) : 2459 - 2462
  • [34] PHASE-I AND PHASE-II TRIAL OF 4'-(9-ACRIDINYLAMINO)METHANESULFON-META-ANISIDIDE IN PATIENTS WITH ACUTE-LEUKEMIA
    ARLIN, ZA
    SKLAROFF, RB
    GEE, TS
    KEMPIN, SJ
    HOWARD, J
    CLARKSON, BD
    YOUNG, CW
    CANCER RESEARCH, 1980, 40 (09) : 3304 - 3306
  • [35] 4’-(9-Acridinylamino)Methanesulfon-m-Anisidide(AMSA)——一种治疗成人急性白血病有效的新药
    卢昌沅
    国外医学输血及血液学分册., 1981, (04) : 253 - 254
  • [36] PHASE-1 CLINICAL INVESTIGATION OF 4'-(9-ACRIDINYLAMINO)METHANESULFON-M-ANISIDIDE (NSC 249992), A NEW ACRIDINE DERIVATIVE
    LEGHA, SS
    GUTTERMAN, JU
    HALL, SW
    BENJAMIN, RS
    BURGESS, MA
    VALDIVIESO, M
    BODEY, GP
    CANCER RESEARCH, 1978, 38 (11) : 3712 - 3716
  • [37] HYDROXYUREA POTENTIATION OF THE ANTINEOPLASTIC ACTIVITY OF CYCLOPHOSPHAMIDE AND 4'-(9-ACRIDINYLAMINO)METHANESULFON-M-ANISIDIDE (AMSA) IN THE BROWN NORWAY RAT MYELOCYTIC-LEUKEMIA MODEL
    VAUGHAN, WP
    HOLM, C
    CORDEL, K
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1989, 23 (01) : 26 - 30
  • [38] PHASE-II STUDY OF 4'-(9-ACRIDINYLAMINO)METHANESULFON-META-ANISIDIDE (NSC 249992) IN CHILDREN WITH ACUTE-LEUKEMIA AND LYMPHOMA
    TAN, CTC
    HANCOCK, C
    STEINHERZ, PG
    STEINHERZ, LJ
    SORELL, M
    CHAN, KW
    MONDORA, A
    MILLER, DR
    CANCER RESEARCH, 1982, 42 (04) : 1579 - 1581
  • [39] TREATMENT OF ACUTE-LEUKEMIA IN RELAPSE WITH 4'(9-ACRIDINYLAMINO) METHANESULFON-M-ANISIDIDE (ASMA) IN COMBINATION WITH CYTOSINE-ARABINOSIDE AND THIOGUANINE
    ARLIN, ZA
    FLOMENBERG, N
    GEE, TS
    KEMPIN, SJ
    DELLAQUILA, C
    MERTELSMANN, R
    STRAUS, DJ
    YOUNG, CW
    CLARKSON, RD
    CANCER CLINICAL TRIALS, 1981, 4 (03) : 317 - 321
  • [40] THE PRODUCTION OF TOPOISOMERASE-II-MEDIATED DNA CLEAVAGE IN HUMAN-LEUKEMIA CELLS PREDICTS THEIR SUSCEPTIBILITY TO 4'-(9-ACRIDINYLAMINO)METHANESULFON-M-ANISIDIDE (M-AMSA)
    BAKIC, M
    BERAN, M
    ANDERSSON, BS
    SILBERMAN, L
    ESTEY, E
    ZWELLING, LA
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1986, 134 (02) : 638 - 645
12345